Image: AI-generatedCase study · Pharma · APOGEPHA
Adverse event reports in a fifth of the time.
Reports used to be analysed by hand. Together we built an AI solution that meets strict pharma requirements and runs in daily operations.
Results at a glance
- 80 %less processing time per report
- 35 %better detection of relevant cases
- GxPcompliant with pharma regulations
- PV Lensresulting product for the industry
What was the problem?
Pharmacovigilance is legally required and highly complex: more than 1,000 reports a year, each one an individual case, information from many sources. For years it could not be automated in a meaningful way.
What did we build?
An AI solution that supports the workflow in three steps and meets GxP requirements.
- Capture information
- Check relevance with AI
- Assess and document professionally
The AI supports the work. Responsible staff remain accountable for the professional assessment.
What changed?
Adverse event reports are analysed in a fifth of the time, and relevant cases are detected 35% better. The solution runs in daily operations.
What comes next?
What works in-house is needed by other pharma companies too. That is why we are building a product from it together with APOGEPHA: PV Lens, a market solution for mid-sized pharma companies.
From core process to new business
The case connects both areas: 01 Optimise core processes for today’s workflow and 02 Evolve business models for tomorrow’s product.
More case studies
What others have built with us.
IKEA
Built and launched a marketplace.
From retailer to platform, now in more than three markets.
Provinzial
Built more than four new businesses.
Steered through a dedicated Digital Growth Board.
Bosch
Prepared the global launch of a new offering.
Launch strategy for L.OS.
